|
| |
| |
|
Dear Colleagues,
With the publication of the FY13 University of California Report on Technology Transfer, I want to highlight and celebrate the achievements of UCLA last year. Relative to our UC peers, we are at or near the top of all major metrics for one of the largest university systems in the world:
- #1 in inventions reported, patents filed, US patents issued, letter of intent agreements, and startups launched
- #2 in licenses executed, licensing income, and financial distributions to campus and inventors
- 2 of the top 5 royalty-producing inventions for UC
These results speak to the first-class research ongoing at UCLA, as well as senior leadership’s commitment to foster an entrepreneurial culture on campus.
In FY2014, we expect the trend to continue, with more disclosures, more licenses, and more sponsored research and licensing income to campus. For context, we expect to launch more research-based startups in FY2014 than Stanford or MIT.
Finally, I want to thank the staff of OIP-ISR for their contributions, and their continued commitment to making UCLA a singular institution for translating research for the benefit of society.
Sincerely,
Brendan Rauw
Associate Vice Chancellor and Executive Director of Entrepreneurship
UCLA Office of Intellectual Property & Industry Sponsored Research
|
|
UC FY13 Tech-Transfer Report: UCLA #1 in Startups
In FY 2013, UC researchers submitted 1,727 new inventions; entered into 427 new IP licensing agreements; and launched 71 new startup companies. UCLA ranked highest in these and other technology transfer metrics featured in the report. |
|
|
UCLA Startup, ImaginAb, Raise $21M Series B Financing
ImaginAb has raised $21 million in additional venture funding to advance its antibody-re-engineering technology, a biotech approach to imaging that the company believes will help personalize treatments for cancer and immune disease. |
|
|
|
UCLA Innovation Featured at UC-wide Tech Forum
20 University of California inventors presented their innovative research at UC’s annual Technology Commercialization Forum held recently in SF. The work spanned a huge array of fields and came from eight UC campuses and LBNL. |
|
|
|
Intellectual Property Announcements
New U.S. Patents Awarded
-
8,734,799 - Unconjugated anti-TfR antibodies and compositions thereof for the. . . | M. Penichet, et al.
-
8,728,744 - Salivary protein biomarkers for human oral cancer | D. Wong, et al.
-
8,728,361 - Making nanostructured porous hollow spheres with tunable structure | Y. Lu, et al.
-
8,717,437 - End-to-end visual recognition system and methods | S. Soatto, et al.
-
8,716,246 - Azuvirin peptides | R. Lehrer, et al.
-
8,703,920 - Fully human antibodies against N-cadherin | R. Reiter, et al.
~~~~
New UCLA Technologies Available for Licensing
SEARCH MORE TECHNOLOGIES
~~~~
'Roundup: UCLA Startup Funding and IP Licensing Highlights
|
|
|
|
|
|
|
UCLA Invents Newsletter, Vol. 2, No. 10
How to Subscribe:
http://oip.ucla.edu/UCLAinvents
View Newsletter Archive
Send editorial comments and corrections to:
Bob Nidever, Editor, bnidever@research.ucla.edu
Contributors: Neil Bajpayee, Ben Dibling, Howard Chang
UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu
Copyright © 2014 The Regents of the University of California. All Rights Reserved.
|
|
|
|
